<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1164">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05145998</url>
  </required_header>
  <id_info>
    <org_study_id>17-191</org_study_id>
    <nct_id>NCT05145998</nct_id>
  </id_info>
  <brief_title>Metabolic Effects of Pulse Consumption on Biomarkers in Adults With Type 2 Diabetes or Met Syn</brief_title>
  <acronym>PGRIV</acronym>
  <official_title>Metabolic Effects of Pulse Consumption on Biomarkers in Adults With Type 2 Diabetes Mellitus or Metabolic Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Iowa State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>USA Dry Pea &amp; Lentil Council</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Iowa State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine glycemic response of four different meals&#xD;
      containing either whole green peas, whole lentils, powdered green peas, or powdered lentils&#xD;
      in comparison to Glucola. Participants are adults with type 2 diabetes mellitus or metabolic&#xD;
      syndrome.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The 5 test treatments (Glucola, whole green peas, green pea flour, whole lentils, and lentil&#xD;
      flour) will be administered randomly over five weeks. The test Participants will be required&#xD;
      to consume the entire test treatment meal in 12 minutes while being observed. Venous blood&#xD;
      samples will be collected for blood glucose and insulin levels at time 0 (fasting) and at 30,&#xD;
      60, 90, 120, and 180 minutes post-treatment (timing of the post-treatment blood draws started&#xD;
      at time 0 [post-treatment], which is when the participant finishes consuming the treatment&#xD;
      meal). During the first visit blood was drawn for a lipid panel and HbA1C values. Thyroid&#xD;
      stimulating hormone (TSH) and complete blood count (CBC) values were analyzed during the&#xD;
      second visit, and vitamin D levels analyzed during the final visit. Blood analysis was&#xD;
      completed by a reputable biomarker diagnostics laboratory, Quest Diagnostics. Anthropometric&#xD;
      measures such as weight, height, waist circumference, and blood pressure were collected at&#xD;
      screening and at the start of each test day. Thirteen hours before testing, participants&#xD;
      consumed a standardized frozen meal to reduce the potential variation in glycemic responses&#xD;
      on test day due to varying pre-evening dietary intakes. This control meal was selected by&#xD;
      each participant before the start of the study. Each participant was provided the same frozen&#xD;
      meal every time, since the subjects serve as their own controls. The day before test day,&#xD;
      participants completed a 24 hour food recall, satiety, and gastrointestinal questionnaires.&#xD;
      The morning of each test day participants completed the International Physical Activity&#xD;
      Questionnaire (IPAQ), satiety, and gastrointestinal questionnaires. Test meal and blood&#xD;
      glucose results at the 5 test points were entered into SPSS statistical software (V. 25) for&#xD;
      data cleaning and analysis. Physical activity and the 24 hour dietary recall data were used&#xD;
      to classify individuals on activity and dietary quality. Satiety responses were compared&#xD;
      against each of the 5 test meals for each participant as well as the gastrointestinal&#xD;
      responses using SPSS.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 23, 2018</start_date>
  <completion_date type="Actual">February 29, 2020</completion_date>
  <primary_completion_date type="Actual">February 29, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>5 x 5 crossover study with 4 treatments and one control</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in baseline blood glucose over 3 hours (glycemic response)</measure>
    <time_frame>Time 0 (fasting) then every 30 minutes for 3 hours</time_frame>
    <description>Venous blood samples were collected via venous catheter. Whole blood samples were analyzed for glucose content and insulin at Quest Diagnostics.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in gastrointestinal symptoms</measure>
    <time_frame>3 hours postprandial, and 12 hours postprandial</time_frame>
    <description>Gastrointestinal concerns and changes were noted on a descriptive questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in satiety sensation</measure>
    <time_frame>Time 0 (fasting) then every 30 minutes for 3 hours</time_frame>
    <description>Satiety level measured using a visual analog scale (0-100) every 30 minutes postprandially. A higher score indicates greater satiety.</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">19</enrollment>
  <condition>Type2 Diabetes Mellitus</condition>
  <condition>Metabolic Syndrome</condition>
  <arm_group>
    <arm_group_label>Control - Glucola</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Glucola control beverage</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Whole peas</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Whole cooked peas in a 50 gram carbohydrate meal dose</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pea Flour</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Pea flour in a 50 gram carbohydrate meal dose</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Whole lentils</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Whole cooked lentils in a 50 gram carbohydrate meal dose</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lentil flour</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lentil flour in a 50 gram carbohydrate meal dose</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Glucola</intervention_name>
    <description>50 grams of Glucola sugar beverage</description>
    <arm_group_label>Control - Glucola</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Whole pea meal</intervention_name>
    <description>Whole cooked peas with spaghetti sauce and a slice of bread.</description>
    <arm_group_label>Whole peas</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Pea flour meal</intervention_name>
    <description>Pea flour with spaghetti sauce and a slice of bread.</description>
    <arm_group_label>Pea Flour</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Whole lentils</intervention_name>
    <description>Whole cooked lentils with spaghetti sauce and a slice of bread.</description>
    <arm_group_label>Whole lentils</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Lentil flour</intervention_name>
    <description>Lentil flour with spaghetti sauce and a slice of bread.</description>
    <arm_group_label>Lentil flour</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 24-70 years&#xD;
&#xD;
          -  BMI between 22-40&#xD;
&#xD;
          -  Medical diagnosis of type 2 diabetes&#xD;
&#xD;
          -  HbA1C &lt;10%)&#xD;
&#xD;
          -  OR have 3+ indicators of metabolic syndrome (high triglycerides, low HDL-cholesterol,&#xD;
             high blood pressure) plus prediabetes HbA1c.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Uncontrolled hypertension or other health issues, e.g., gastrointestinal disease&#xD;
&#xD;
          -  Weight changes of &gt;10% of participants body weight within a 6 month period&#xD;
&#xD;
          -  Pregnant or breastfeeding&#xD;
&#xD;
          -  Allergy to peas, lentils, tomatoes, gluten, or latex&#xD;
&#xD;
          -  HgbA1c level of &gt;10% at screening&#xD;
&#xD;
          -  Unwillingness or inability to follow study protocol.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>24 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Donna Winham, DrPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Iowa State University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Iowa State University, Food Science and Human Nutrition Department</name>
      <address>
        <city>Ames</city>
        <state>Iowa</state>
        <zip>50011</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>January 16, 2020</study_first_submitted>
  <study_first_submitted_qc>November 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 6, 2021</study_first_posted>
  <last_update_submitted>November 23, 2021</last_update_submitted>
  <last_update_submitted_qc>November 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Iowa State University</investigator_affiliation>
    <investigator_full_name>Donna Winham</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Glycemic response</keyword>
  <keyword>Glucose</keyword>
  <keyword>Type 2 diabetes</keyword>
  <keyword>Legumes</keyword>
  <keyword>Metabolic Syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Metabolic Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

